Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2004
10/19/2004US6806274 Quinazoline derivatives
10/19/2004US6806230 Pyrimidine derivatives and herbicides containing them
10/19/2004CA2296901C Piperidine derivates having anxiolytic effect
10/18/2004CA2464961A1 Polymorphous forms of rosiglitazone maleate
10/14/2004WO2004087714A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
10/14/2004WO2004087699A2 Thiazoles useful as inhibitors of protein kinases
10/14/2004WO2004087698A2 Thiazoles useful as inhibitors of protein kinases
10/14/2004WO2004087694A1 A heterocycle-substituted benzoxazine compounds having bioactivity
10/14/2004WO2004087690A2 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
10/14/2004WO2004087687A1 Chromene derivatives as anti-inflammatory agents
10/14/2004WO2004087669A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
10/14/2004WO2004087663A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/14/2004WO2004087646A2 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
10/14/2004WO2004087641A1 Hydrazone derivative
10/14/2004WO2004087142A1 Quinoline-2-one-derivatives for the treatment of airways diseases
10/14/2004WO2004087053A2 Dipeptidyl peptidase inhibitors
10/14/2004WO2004087051A2 Ophthalmic compositions for treating ocular hypertension
10/14/2004WO2004087050A2 Mitotic kinesin inhibitors
10/14/2004WO2004087048A2 Benzamide modulators of metabotropic glutamate receptors
10/14/2004WO2004050636A3 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
10/14/2004WO2004037176A3 Quinazolinones and derivatives thereof as factor xa inhibitors
10/14/2004WO2004000785A3 Phenyloxyalkanonic acid derivatives as hppar activators
10/14/2004US20040204591 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group
10/14/2004US20040204588 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones
10/14/2004US20040204586 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/14/2004US20040204584 Alzheimer's disease; Parkinson's disease; antidepressants
10/14/2004US20040204500 Preventives/remedies for organ functional disorders and organ dysfunction
10/14/2004US20040204498 Pyrimidine carboxamides; 5-hydroxy-2-(2-(1,1-Dioxo-6-[1,2]thiazinan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides; AIDS; AIDS related complex
10/14/2004US20040204477 For use as antiproliferative agents
10/14/2004US20040204454 Lactam-containing cyclic diamines and derivatives as factor Xa inhibitors
10/14/2004US20040204450 For therapy of atherosclerosis, coronary artery disease, coronary heart disease, coronary vascular disease, peripheral vascular disease, dyslipidemia, hyperbetalipoproteinemia, hypoalphalipoproteinemia, hypercholesterolemia, hypertriglyceridemia, familial-hypercholesterolemia
10/14/2004US20040204446 Nitrogen compounds such as N-(2-Fluoro-benzyl)-N-indan-2-yl-2-(3-methyl-2-o-tolyl-piperidin-1-yl) -acetamide, administered for prophylaxis arthritis, psoriasis, cardiovascular disorders, reperfusion injury or respiratory system disorders
10/14/2004US20040204437 Substituted arylamine derivatives and methods of use
10/14/2004US20040204421 Certain 1,3-disubstituted isoquinoline derivatives
10/14/2004US20040204412 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer
10/14/2004US20040204408 Piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity
10/14/2004US20040204407 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors
10/14/2004US20040204406 Pyrazole-derivatives as factor Xa inhibitors
10/14/2004US20040204257 System for and a method of manufacturing personal golf putters
10/14/2004DE10315377A1 New carbonyl-substituted carbocyclic or heterocyclic compounds, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation or tumors
10/14/2004CA2523126A1 Thiazoles useful as inhibitors of protein kinases
10/14/2004CA2523125A1 Thiazoles useful as inhibitors of protein kinases
10/14/2004CA2521056A1 Hydrazone derivative
10/14/2004CA2520896A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
10/14/2004CA2520493A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/14/2004CA2520281A1 Benzimidazole derivatives and their use for modulating the gabaa recept or complex
10/14/2004CA2519954A1 Benzamide modulators of metabotropic glutamate receptors
10/14/2004CA2519899A1 Ophthalmic compositions for treating ocular hypertension
10/14/2004CA2519291A1 Chromene derivatives as anti-inflammatory agents
10/14/2004CA2518913A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
10/14/2004CA2518465A1 Dipeptidyl peptidase inhibitors
10/13/2004EP1466912A1 2-acylaminothiazole derivative or salt thereof
10/13/2004EP1466902A1 Androgen receptor antagonists
10/13/2004EP1466901A1 Serotonine reuptake inhibitor
10/13/2004EP1465891A2 Inhibitors of dipeptidyl peptidase iv
10/13/2004EP1465888A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
10/13/2004EP1465882A2 Hetrocyclic modulators of nuclear receptors
10/13/2004EP1465881A2 Hydrogenation of precursors to thiazolidinedione antihyperglycemics
10/13/2004EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
10/13/2004EP1465872A1 4-sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
10/13/2004EP1465869A1 Modulators of lxr
10/13/2004EP1465863A1 Potassium channel modulators
10/13/2004EP1465862A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
10/13/2004EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
10/13/2004EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
10/13/2004EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/13/2004EP1322309A4 High affinity small molecule c5a receptor modulators
10/13/2004EP1280797B1 Inhibitors of dipeptidyl peptidase iv
10/13/2004EP1169038A4 Cyclic protein tyrosine kinase inhibitors
10/13/2004EP1104761B1 Fluorescent labelling reagents
10/13/2004EP1097142B1 Phthalazine derivatives phosphodiesterase 4 inhibitors
10/13/2004EP0824317B1 An agricultural and horticultural disease controller and a method for controlling the diseases
10/13/2004CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators
10/13/2004CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative
10/13/2004CN1535966A Indazole derivative for pestide
10/13/2004CN1170827C Benzofurylpyrone deriuvatives
10/13/2004CN1170826C Amide compounds
10/13/2004CN1170819C Piperidine alcohols
10/12/2004USRE38624 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation
10/12/2004US6803370 Compounds for use in the treatment of asthma, alzheimer's, diabetes, atherosclerosis, inflammatory bowel disease, arthritis, tumor metastasis, ischemia and brain disorders
10/12/2004US6803129 Organic light emitting diode and organic luminescent materials thereof
10/07/2004WO2004085435A1 Process for preparing a polymorph of rosiglitazone maleate
10/07/2004WO2004085433A2 Positive allosteric modulators of the nicotinic acetylcholine receptor
10/07/2004WO2004085408A1 2, 3, 6-trisubstituted-4-pyrimidone derivatives
10/07/2004WO2004085401A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity
10/07/2004WO2004085388A2 Cyclic protein tyrosine kinase inhibitors
10/07/2004WO2004084901A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
10/07/2004WO2004084813A2 Chemical compounds
10/07/2004WO2004084634A1 N-phenyl- ‘ (4-pyridyl)- azinyl!amine derivatives as plant protection agents
10/07/2004WO2004065392A8 Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
10/07/2004WO2004060362B1 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β
10/07/2004WO2004041164A3 Kinase inhibitors
10/07/2004US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis
10/07/2004US20040198980 Selective rxr ligands
10/07/2004US20040198796 Compounds and methods for treating urinary incontinence
10/07/2004US20040198793 Chemical process and new intermediates
10/07/2004US20040198790 Triazole compound containing a phosphonate group
10/07/2004US20040198786 Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
10/07/2004US20040198774 Preventive and/or remedial agent for disease attributable to arteriosclerotic activity
10/07/2004US20040198768 Method for inhibiting 5-lipoxygenase using a benzoxazole derivative or an analogue thereof
1 ... 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 ... 628